Elan Corporation

DUBLIN, Ireland--(BUSINESS WIRE)--April 11, 2005--Elan Corporation, plc today announced that it will report its first quarter 2005 financial results on April 28, 2005, before U.S. and European financial markets open. The results announcement will be followed by a conference call at 8:30 a.m. Eastern Time (ET), 1:30 p.m. British Summer Time (BST) with the investment community to discuss Elan's first quarter 2005 financial results. Live audio of the conference call will be simultaneously broadcast over the Internet and will be available to investors, members of the news media and the general public. This event will be webcast live and can be accessed by going to the Investor Relations section on Elan's website at www.elan.com.

Elan will hold its Annual General Meeting at 10:00 a.m. BST on May 26, 2005 at the Westin Hotel, Westmoreland Street, Dublin 2, Ireland. This event will also be webcast live and can be accessed by going to the Investor Relations section on Elan's website at www.elan.com.

Elan has filed with the Securities and Exchange Commission its Form 20-F for the fiscal year ended December 31, 2004 and has published its Annual Report for the fiscal year ended December 31, 2004. Both these documents are available on the Investor Relations section of Elan's website at www.elan.com.

About Elan

Elan Corporation, plc is a neuroscience-based biotechnology company that is focused on discovering, developing, manufacturing and marketing advanced therapies in neurology, autoimmune diseases, and severe pain. Elan (NYSE: ELN) shares trade on the New York, London and Dublin Stock Exchanges.

CONTACT: Elan 
Investors:
Emer Reynolds, 353-1-709-4000 / 800-252-3526
or
Media:
Anita Kawatra, 212-407-5740
Elizabeth Headon, 353-1-498-0300

SOURCE: Elan Corporation, plc